The latest glucagon-like peptide 1 (GLP-1) receptor agonists have been heralded for their potential to not only boost weightloss and glucose ... tirzepatide, and new GLP-1 drugs in the ...
Compounded by the equally sudden banning of the weightlossdrug, phen-fen (phentermine-fenfluramine ... there remained no new promising pharmaceutical agents addressing obesity.